BRISTOL MYERS SQUIBB CO (BMY) earnings date
Feb 4, 2027, before open estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 52% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 30 days, typically, give or take 4 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Thu, Oct 29, 2026 | before open | 29 | 8-K |
| Q2 FY2026 | Thu, Jul 30, 2026 | before open | 30 | 8-K |
| Q1 FY2026 | Thu, Apr 30, 2026 | before open | 30 | 8-K |
| Q4 FY2025 | Thu, Feb 5, 2026 | before open | 36 | 8-K |
| Q3 FY2025 | Thu, Oct 30, 2025 | before open | 30 | 8-K |
| Q2 FY2025 | Thu, Jul 31, 2025 | before open | 31 | 8-K |
| Q1 FY2025 | Thu, Apr 24, 2025 | before open | 24 | 8-K |
| Q4 FY2024 | Thu, Feb 6, 2025 | before open | 37 | 8-K |
What they guided beta
| Q3 FY2026 | "Document Exhibit 99.1 Bristol Myers Squibb Reports Third Quarter Financial Results for 2026 and Raises Full-Year Revenue Outlook Growth Portfolio Performance and Disciplined Execution Drive Strong Financial Results Key Pipeline Milestones Include Regulatory Approvals and Positive Registrational Data Across Multiple Therapeutic Areas" exhibit |
| Q3 FY2026 | "Raising 2026 revenue guidance to a range of $49.75 billion to $50.25 billion; Updating non-GAAP EPS range to $6.35 to $6.55, inclusive of a $(0.60) per share net impact from Acquired IPRD charges and licensing income (PRINCETON, N.J., October 29, 2026) – Bristol Myers Squibb (NYSE: BMY) today reports results for the third quarter of 2026." exhibit Read from the sentence: revenue $49.75 billion to $50.25 billion, FY2026 |
| Q3 FY2026 | "Construction is expected to begin this year on the approximately 225,000-square-foot facility, which will complement RayzeBio's existing footprint in the state and will create up to 100 new jobs by the end of 2029." exhibit |
| Q3 FY2026 | "Financial Guidance Bristol Myers Squibb is increasing its full-year, non-GAAP revenue guidance from a range of approximately $49.0 billion to $50.0 billion to a range of approximately $49.75 billion to $50.25 billion." exhibit |
| Q3 FY2026 | "Full-year other income/(expense) is now expected to be ~$650 million of expense, due to favorable net interest." exhibit |
| Q2 FY2026 | "Document Exhibit 99.1 Bristol Myers Squibb Reports Second Quarter Financial Results for 2026 and Raises Full-Year Outlook Strong Performance Underscores Growth Portfolio Momentum and Pipeline Progress" exhibit |
| Q2 FY2026 | "Raising 2026 revenue guidance to a range of ~$49.0 billion to $50.0 billion; Increasing non-GAAP EPS range to $6.75 to $7.00 (PRINCETON, N.J., July 30, 2026) – Bristol Myers Squibb (NYSE: BMY) today reports results for the second quarter of 2026." exhibit Read from the sentence: revenue $49 billion to $50 billion, FY2026 |
| Q2 FY2026 | "As a result of our consistent execution and continued momentum, we are raising our 2026 full-year outlook." Second Quarter Results $ in millions, except per share amounts 2026 2025 Change Change Excl." exhibit |
| Q2 FY2026 | "Financial Guidance Bristol Myers Squibb is increasing its full-year, non-GAAP revenue guidance from a range of approximately $46.0 billion to $47.5 billion to a range of approximately $49.0 billion to $50.0 billion." exhibit |
| Q2 FY2026 | "Full-year operating expenses in 2026 are now expected to be approximately $16.5 billion, due to increased investment behind key pipeline programs and new product launches." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/BMY
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/BMY
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/BMY/"><img src="https://veritasdata.dev/embed/BMY.svg" alt="BMY earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/BMY/)
Script
<script async src="https://veritasdata.dev/embed/BMY.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/BMY"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.